A Prospective Phase 2 Study of PEmetrexed in Combination With Cisplatin in Patients With Advanced UrotheLIal CAnceR.
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2014
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- Acronyms PECULIAR
- 22 Sep 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Apr 2014 Status changed from recruiting to active, no longer recruiting.
- 01 Feb 2014 Interim results presented at the 2014 Genitourinary Cancers Symposium.